Introduction {#sec1}
============

Before every cell division, our genetic material needs to be duplicated and assembled into two equal packages that can be faithfully transmitted to the next generation. The temporal coordination of molecular events such as DNA replication, repair, and chromosome segregation is therefore critical for the maintenance of genome integrity. Homologous recombination (HR), although essential for the repair of DNA breaks and the restoration of damaged replication forks, can occasionally create a block to chromosome segregation by generating covalently linked DNA intermediates such as Holliday junctions (HJs) ([@bib6; @bib24; @bib47]). These joint molecules (JMs) constitute a physical connection between sister chromatids or homologous chromosomes, and their timely removal is needed to avoid any interference with normal chromosome segregation.

Cells possess a battery of helicases and nucleases that can deal with HR intermediates. For example, in *S. cerevisiae* there are two major pathways for the processing of late HR intermediates. The first, mediated by the Sgs1-Top3-Rmi1 (STR) complex, specializes in the elimination of double HJs (dHJs) that arise from HR-mediated strand break repair ([@bib8; @bib10]). For this, the RecQ-family helicase Sgs1 catalyzes the convergent branch migration of two HJs, resulting in a hemicatenate structure that is decatenated by the type I topoisomerase Top3. A related mechanism of double HJ "dissolution" occurs in human cells, driven by BLM-TopoIIIα-RMI1-RMI2 (BTR complex) and is important for the avoidance of sister chromatid exchanges and loss of heterozygosity ([@bib33; @bib48]). Indeed, STR/BTR play an important role in limiting crossover (CO) formation by directing the products of recombination to noncrossovers (NCOs). The second pathway for the processing of late HR intermediates involves two structure-selective endonucleases: in yeast, these are the XPF-family endonuclease Mus81-Mms4 ([@bib5; @bib14; @bib25; @bib29]) and the XPG-family member Yen1 ([@bib3; @bib26]). Again, there is a good analogy with human systems, where MUS81-EME1 and GEN1 are important for promoting Holliday junction "resolution" ([@bib9; @bib11; @bib19; @bib26; @bib46; @bib49]). These reactions, unlike STR/BTR, have the potential to promote both the formation of NCO and CO products. Therefore, the choice of pathway for the removal of late HR intermediates directs the outcome of repair, with NCO pathways being the preferred choice in mitotic cells ([@bib27]).

How the processing of recombination intermediates is biased toward NCOs in mitosis has been the focus of extensive research. In *sgs1Δ* mutants, the elimination of JMs is delayed until G2/M, becomes dependent on Mus81-Mms4, and results in increased CO formation ([@bib12; @bib27]). Consistent with these observations, *sgs1Δ mus81Δ* double mutants are synthetically lethal due to the accumulation of toxic HR intermediates ([@bib17]), indicating that Mus81-Mms4 resolves HR intermediates that escape the actions of the STR complex at earlier stages of the cell cycle. The DNA repair deficiency of *mus81Δ* and *mms4Δ* mutants is exacerbated by further deletion of *YEN1*, and *mus81*Δ *yen1*Δ double mutants display both aberrant chromosome segregation and reduced mitotic CO formation ([@bib3; @bib23]). Thus, Yen1 provides an additional mechanism for JM resolution.

The apparent hierarchy among the STR complex, Mus81-Mms4, and Yen1 for DNA damage repair is supported by observations showing that Mus81-Mms4 and Yen1 are sequentially activated in two waves that occur late in the cell cycle. Cdk/Cdc5-mediated phosphorylation of Mms4 drives the hyperactivation of Mus81-Mms4 at the G2/M transition, whereas S phase phosphorylation of Yen1 holds this protein in an inactive state until it is activated at anaphase ([@bib18; @bib34; @bib35; @bib42]). Intuitively, such a regulatory mechanism creates a window during S/G2 in which the NCO-promoting pathways have preferential access to the majority of repair intermediates. Any persistent dHJs, and single HJs that might arise from replication fork processing, would then be captured by Mus81-Mms4 in G2/M or by Yen1 in anaphase, thus ensuring the segregation of DNA. The temporal restriction of Mus81-Mms4 and Yen1 activities to late stages of the cell cycle may also be important to protect against the unscheduled cleavage of DNA replication intermediates that arise during S phase.

Although the biochemical properties of Mus81-Mms4 have been studied extensively, the biochemical properties of Yen1 (759 amino acids) or its human ortholog GEN1 (908 amino acids) have yet to be determined. Indeed, the analysis of Yen1 has been restricted to immunoprecipitates, whereas most studies of GEN1 were carried out with a purified N-terminal fragment (GEN1^1-527^) of the protein ([@bib26; @bib34; @bib37]). Like other members of the XPG family of 5′-flap endonucleases, Yen1/GEN1 exhibit 5′-flap and fork cleavage activities, but, unique to this nuclease family, Yen1 and GEN1 cleave HJs by the introduction of symmetrically related nicks across the junction to produce ligatable nicked duplex products.

Yen1 is a target of the S phase cyclin-dependent kinase Cdk, and its subcellular localization is cell-cycle-regulated in a Cdk-dependent manner ([@bib30; @bib32; @bib43]). However, we know very little about the mechanism of Yen1 inhibition during S phase, how it is activated at anaphase, or how these dynamic cycles of inactivation/activation are coupled with cell-cycle progression. Here, we investigate the mechanism of Yen1 regulation, in terms of its biochemical activation and subcellular localization, and show how both are linked to cell-cycle control. Importantly, we demonstrate that Cdk and the mitotic exit phosphatase Cdc14 ([@bib41]) constitute the "off" and "on" switches for Yen1 function, respectively. Employing Yen1 mutants that are refractory to Cdk-dependent inhibition and are constitutively active throughout the cell cycle, we show that premature activation of Yen1 results in DNA damage sensitivity and increased loss of heterozygosity. The purification of full-length Yen1, in both the phosphorylated and nonphosphorylated states, revealed that the mechanistic basis of inhibition lies in modulation of the DNA binding activity of the protein. As such, Yen1 is uniquely regulated at two distinct levels, by both biochemical inhibition and by nuclear exclusion, until anaphase when the protein is activated and undergoes nuclear entry in response to Cdc14-mediated dephosphorylation.

Results {#sec2}
=======

Generation of a Constitutively Active Form of Yen1 {#sec2.1}
--------------------------------------------------

Yen1 regulation involves cycles of phosphorylation and dephosphorylation that control both its activity and cellular localization ([@bib30; @bib34]). To determine the sites of phosphorylation, affinity-purified Yen1 was analyzed by mass spectrometry, revealing a total of 25 different phosphorylated residues ([Figure 1](#fig1){ref-type="fig"}A). Several phosphorylated serines and threonines were located in consensus target sequences for cell-cycle control and DNA damage response kinases, including Cdk (S/T-P; S71, S245, S500, S583, S655, S679), Mec1/Tel1 (S/T-Q; S80, S498, T664), and Cdc5 (D/E-X-S/T-ϕ-X-D/E; S614). Although our peptide coverage for Yen1 was incomplete, it is significant that phosphorylation was detected in six of the nine predicted Cdk-consensus sites.

Using this information, and the fact that Yen1 is a known target of Cdk, we generated a collection of *YEN1* alleles with mutations in the identified/predicted phosphoresidues ([Figure S1](#app2){ref-type="sec"} available online). One allele, named *YEN1*^*ON*^, in which the serines in all nine Cdk consensus sites were mutated to alanine, was of particular interest because immunoprecipitates (IPs) of Yen1^ON^-myc9 displayed a greater HJ resolvase activity than Yen1-myc9, as measured by the conversion of a ^32^P-labeled HJ into nicked duplex products ([Figure 1](#fig1){ref-type="fig"}B, compare lanes 2 and 4). Moreover, we found that constitutive expression of Yen1^ON^ from a plasmid resulted in increased cellular sensitivity to the DNA-damaging agent methyl methanesulfonate (MMS) ([Figure 1](#fig1){ref-type="fig"}C), whereas expression of the wild-type protein or a catalytically inactive form of Yen1 (Yen1^EEAA^, in which residues E193 and E195 were converted to alanine) did not affect MMS sensitivity. In contrast to Yen1, which exhibited little HJ resolvase activity in S phase but was activated at anaphase, Yen1^ON^ was constitutively active throughout the entire cell cycle ([Figure 1](#fig1){ref-type="fig"}D, compare lanes 6--8 with 14--16), explaining the high levels of activity observed in asynchronous cultures ([Figure 1](#fig1){ref-type="fig"}B, lane 4).

Among the different phosphomutants generated, containing between 1 and 17 amino acid changes ([Figure S1](#app2){ref-type="sec"}), *YEN1*^*ON*^ exhibited constitutive nuclease activity and the strongest sensitivity to DNA-damaging agents, coupled with the lowest number of amino acid substitutions ([Figure 1](#fig1){ref-type="fig"}C; data not shown). It was therefore selected for further study. Analysis of the other mutants, however, showed that Yen1 inhibition during S phase was primarily dependent on the phosphorylation status of S500, S507, S513, and S583, located in the central region of Yen1 (compare Yen1^4A^ and Yen1^5A^ in [Figure S1](#app2){ref-type="sec"}).

Deregulated Yen1 Resolves HR Intermediates Leading to Increased CO Frequency and Defective DNA Repair {#sec2.2}
-----------------------------------------------------------------------------------------------------

To determine the consequences of Yen1 deregulation in more detail, we constructed strains in which the endogenous *YEN1* allele was replaced with *YEN1*^*ON*^. Cells harboring *YEN1*^*ON*^ displayed increased sensitivity to high doses of MMS, but not hydroxyurea (HU) ([Figure 2](#fig2){ref-type="fig"}A). Remarkably, *YEN1*^*ON*^ fully suppressed the DNA damage sensitivity of *mus81Δ* strains, which are deficient for the catalytic subunit of the structure-selective endonuclease Mus81-Mms4 ([Figure 2](#fig2){ref-type="fig"}B). *YEN1*^*ON*^ could also partially suppress the MMS sensitivity of *sgs1Δ* mutants, whereas no effect was observed for HU ([Figure 2](#fig2){ref-type="fig"}C). Finally, we found that *YEN1*^*ON*^ rescued the synthetic lethality of *sgs1Δ mus81Δ* double mutants ([Figure 2](#fig2){ref-type="fig"}D). These results show that prematurely activated Yen1 is capable of acting upon recombination intermediates that are normally processed by Mus81-Mms4 or Sgs1.

The action of STR complex early in the cell cycle generates noncrossovers (NCOs) and limits the formation of crossovers (COs) that could lead to loss of heterozygosity (LOH). We therefore reasoned that premature activation of Yen1 would increase CO formation by competing with the NCO-promoting pathways. To test this, we utilized a genetic assay for the detection of unselected products of mitotic recombination after the formation of a single I-SceI-mediated double-strand break at the *ade2-I* locus on chromosome XV ([@bib23]). When we scored the recombination events in a wild-type *YEN1* background, we found 14.2% COs and 80.5% NCOs ([Figure 2](#fig2){ref-type="fig"}E; [Table S1](#app2){ref-type="sec"}). In strains carrying *YEN1*^*ON*^, however, the CO frequency increased significantly to 18.9% at the expense of NCO products, with little effect on the frequency of break-induced replication (BIR) events. These results show that restriction of Yen1 nuclease activity until mitosis is important for efficient DNA repair and to avoid LOH through the formation of excess mitotic COs.

Phosphorylation-Dependent Control of Yen1 Localization {#sec2.3}
------------------------------------------------------

Yen1 has been identified as a protein that undergoes cell-cycle-dependent nucleocytoplasmic relocalization ([@bib30]), and it has been suggested that the subcellular localization of Yen1 is determined by the phosphorylation status of the Cdk consensus site (S679) that overlaps the nuclear localization signal (NLS; 679-[S]{.ul}PIKKSRTT-687). Indeed, overexpressed Yen1 is predominantly nuclear in G1-arrested cells and becomes cytoplasmic after release into S phase in a Cdk-dependent manner. Substitution of S679 with alanine, which abrogates the phosphorylation of the NLS-overlapping Cdk consensus site, promotes a greater extent of nuclear localization throughout the cell cycle ([@bib30]).

S679 is one of the residues mutated to alanine in Yen1^ON^ ([Figure 1](#fig1){ref-type="fig"}B). We therefore used immunofluorescence analyses to determine how this mutational change affected the localization of Yen1^ON^-myc18 (expressed from the endogenous *YEN1* locus) throughout the cell cycle. Control experiments showed that wild-type Yen1 was enriched in the nucleus during G1 but became diffuse throughout the cell during S phase. Yen1 remained cytoplasmic in metaphase, but strikingly relocalized into the nucleus at anaphase ([Figure 3](#fig3){ref-type="fig"}A). In contrast, we did not observe similar dynamics with Yen1^ON^, which was prominently nuclear throughout the cell cycle ([Figure 3](#fig3){ref-type="fig"}B). These results show that Yen1^ON^ is not only deregulated in terms of its biochemical activity, but also in its subcellular compartmentalization.

It was expected that the nuclear enrichment of Yen1^ON^ would be a consequence of the mutational change at S679A. However, we found that Yen1 carrying a single change at this site, Yen1^S679A^, failed to fully recapitulate the localization pattern of Yen1^ON^ ([Figure 3](#fig3){ref-type="fig"}C). These results indicate that additional phosphorylation events contribute to the compartmentalization of Yen1, and this concept was supported by observations with a Yen1^8A^ mutant (identical to Yen1^ON^, except for position S679). This mutant displayed a profile of nuclear enrichment remarkably similar to Yen1^S679A^, confirming that phosphorylation events at Cdk sites other than S679 contribute to the exclusion of Yen1 from the nucleus prior to the onset of anaphase.

Knowledge of the compartmentalization patterns of these mutants also allowed us to investigate whether biochemical activation and localization were interdependent events. IPs of myc-tagged Yen1, Yen1^ON^, Yen1^8A^, Yen1^S679A^, or Yen1^S679D^ from S phase cells revealed that Yen1^8A^, but not Yen1^S679A^, exhibited deregulated HJ resolvase activity ([Figure 3](#fig3){ref-type="fig"}D), although both proteins showed similar levels of nuclear enrichment ([Figure 3](#fig3){ref-type="fig"}C). These results show that the biochemical activation of Yen1 is separable from nuclear relocalization. In accord with this proposal, only the activity-deregulated versions of Yen1 (Yen1^ON^ and Yen1^8A^) were effective in reducing the MMS sensitivity of *mus81Δ* mutants, as the Yen1^S679A^ mutant failed to suppress the *mus81Δ* phenotype despite its nuclear enrichment ([Figure 3](#fig3){ref-type="fig"}E).

The "Yin" Cdk and "Yang" Cdc14 of Yen1 Regulation {#sec2.4}
-------------------------------------------------

We have shown that the cycles of Yen1 activation/inactivation depend on its phosphorylation status and that its nuclease functions are inhibited at S phase ([@bib34]). Yen1 is known to be a target of the cyclin-dependent kinase Cdk (Cdc28), and in particular of the S phase Cdk complex, Cdc28-Clb5 ([@bib32; @bib43]). Because Yen1 localization also depends on Cdk phosphorylation, we determined whether Cdk-mediated phosphorylation was directly responsible for the inhibition of Yen1 activity during S phase. To do this, Yen1-myc9 was expressed under the control of a galactose-inducible promoter (P~*GAL1*~) in cells arrested in S phase that carried the *cdc28-as1* allele, in which Cdk can be specifically inhibited by the addition of ATP-analog 1NM-PP1 ([@bib2]) ([Figure 4](#fig4){ref-type="fig"}A). When Yen1 expression was induced after Cdk inhibition, we observed significantly more HJ resolvase activity than in the absence of inhibitor ([Figure 4](#fig4){ref-type="fig"}B, compare lanes 3 and 4). A similar, although less efficient, boost in activity was observed when Yen1 was induced before Cdk inhibition (lanes 1 and 2). These results demonstrate that Cdk activity is responsible for the inhibition of Yen1 activity in S phase. Consistent with this notion, the activity of Yen1^ON^ could not be further enhanced by Cdk inhibition ([Figure 4](#fig4){ref-type="fig"}C).

We next wanted to determine the identity of the phosphatase that reverses inhibitory phosphorylation and activates Yen1 at anaphase. Cdc14 phosphatase appeared to be a prime suspect for this reaction for several reasons: (1) Cdc14 is released from the nucleolus at the onset of anaphase ([@bib39; @bib45]), at a time that coincides with Yen1 activation; (2) Cdc14 is responsible for the dephosphorylation of several Cdk substrates to allow exit from mitosis ([@bib44]); and (3) Cdc14 displays a preference for targets with phosphoserine over phosphothreonine in the Cdk consensus phosphorylation sites (9:0 for Yen1), and therefore the S-P to T-P ratio is, to some extent, predictive of Cdc14 targets ([@bib7]). We therefore determined whether the absence of Cdc14 would result in a defect in the activation of Yen1. Because *CDC14* is an essential gene, strains carrying the temperature sensitive allele *cdc14-1* were generated. When switched to 37°C, the restrictive temperature at which Cdc14-1 is unstable, we observed a complete lack of activation of Yen1 ([Figure 4](#fig4){ref-type="fig"}D, compare lanes 1 and 2). However, analysis of DNA content by fluorescence-activated cell sorting (data not shown) and the abundance of Clb2 cyclin indicated that we were comparing a cycling population of wild-type cells with a population arrested in anaphase in *cdc14-1* mutants. To eliminate the possibility of cell-cycle-dependent effects, the same experiment was carried out in a *cdc15-2* background. *CDC15* encodes an essential kinase and a component of the mitosis exit network ([@bib1]) such that *cdc15-2* mutants arrest in late anaphase/telophase when switched to the restrictive temperature of 37°C. Under these conditions Yen1 exhibited a robust nuclease activity, whereas little Yen1 activity was observed in *cdc14-1 cdc15-2* double mutants ([Figure 4](#fig4){ref-type="fig"}D, lanes 3 and 4). These results confirm that Cdc14 is responsible for the activation of Yen1 nuclease activity in anaphase. Moreover, in agreement with a direct role of Cdc14 in the dephosphorylation and activation of Yen1, we found that Yen1^ON^ remained active when *cdc14-1* mutants were switched to 37°C ([Figure 4](#fig4){ref-type="fig"}E).

Because both inactivation and nuclear exclusion of Yen1 are driven by Cdk activity, whereas its biochemical activation relies on Cdc14, we next determined whether the nuclear relocalization of Yen1 at anaphase also requires Cdc14. For this purpose, we analyzed the subcellular localization of Yen1 during anaphase both in *CDC14* and *cdc14-1* cells at the restrictive temperature of 37°C ([Figure 4](#fig4){ref-type="fig"}F). In a wild-type (*CDC14*) strain, more than 80% of anaphase cells presented a clear enrichment of Yen1 in the nucleus, whereas Yen1 staining was pan-cellular in most anaphases of *cdc14-1* mutants (85%). Yen1^ON^ was found to bypass the requirement for Cdc14 in re-establishing its nuclear localization, with 94% of the cells displaying nuclear enrichment of the protein after Cdc14 inactivation. These results show that Cdc14 promotes not only the activation of Yen1, but also its nuclear enrichment at anaphase.

Ectopic Expression of Cdc14 in S Phase Is Sufficient to Activate Yen1 {#sec2.5}
---------------------------------------------------------------------

Because our results have shown that Cdc14 is required for Yen1 activation at anaphase, we determined whether inappropriate expression of Cdc14 at other stages of the cell cycle would suffice to activate Yen1. To do this, strains were employed in which the endogenous *CDC14* locus was replaced by the *TAB6-1* allele. This mutant displays reduced nucleolar sequestration of Cdc14 due to a mutation (Cdc14^P116L^) that impairs its interaction with Net1 ([@bib40]). Our prediction was that if more Cdc14 could be made available in the nucleus, then the activity of Yen1 should also be increased. When we analyzed Yen1 in immunoprecipitates from *CDC14* and *TAB6-1* cells arrested in S phase ([Figure 5](#fig5){ref-type="fig"}A), we found that, whereas Yen1 activity was undetectable in wild-type cells, Yen1 from *TAB6-1* mutants displayed elevated activity.

Further evidence to support our observations that Cdc14 is the phosphatase that activates Yen1 was provided by experiments in which Cdc14 was overexpressed from the *GAL1* promoter. We found that Cdc14 overexpression resulted in the dephosphorylation of Yen1 leading to high levels of activity ([Figure 5](#fig5){ref-type="fig"}B, lane 8). However, because it is known that *CDC14* overexpression results in a G1 arrest ([@bib44]), it was necessary to rule out cell-cycle-related effects. To do this, we overexpressed Cdc14 in S phase-arrested cells and found that it was sufficient to trigger a robust activation of Yen1 outside of anaphase ([Figure 5](#fig5){ref-type="fig"}C, lanes 7 and 8).

Finally, to determine whether Yen1 physically interacts with its activator, Cdc14, we took advantage of the Ccd14^D253A^ and Cdc14^C283S^ mutations, which inhibit the catalytic activity of Cdc14, but retain the ability to interact with its targets, effectively behaving as "substrate trapping" mutants ([@bib4]). We found that IPs of both Cdc14^D253A^ and Cdc14^C283S^ contained Yen1. Similarly, an IP of Yen1 contained both Cdc14^D253A^ and Cdc14^C283S^ ([Figure 5](#fig5){ref-type="fig"}D). These results demonstrate that physical interactions occur between Cdc14 and Yen1.

Mechanistic Basis of Yen1 Activation/Inactivation: Phosphorylation Modulates DNA Binding {#sec2.6}
----------------------------------------------------------------------------------------

To understand how changes in the phosphorylation status of Yen1 modulate its nuclease activity, three versions of Yen1 were purified to homogeneity: wild-type Yen1 protein, the catalytically inactive Yen1^EEAA^ mutant, and the phosphomutant Yen1^ON^ ([Figure 6](#fig6){ref-type="fig"}A). Because all three proteins were purified from asynchronous cultures, they would contain a mixture of phosphorylated and nonphosphorylated protein. When equimolar amounts of Yen1 were compared with Yen1^ON^, we observed that Yen1^ON^ exhibited much greater activity ([Figure 6](#fig6){ref-type="fig"}B). We did not, however, observe any changes to the substrate specificity of these two nucleases: both were active upon Holliday junctions (static, mobile, or nicked), replication fork structures, and 5′ flaps. The catalytic-dead mutant Yen1^EEAA^ did not process any of these substrates. Neither Yen1 nor Yen1^ON^ showed any activity toward 3′ flaps, splayed arm, double-stranded, or single-stranded DNA substrates, in agreement with the expected specificity of other members of the XPG family of nucleases ([@bib31]).

Additionally, Yen1 was purified in both fully phosphorylated (Yen1^P^) and dephosphorylated forms (Yen1^λ^), by employing *cdc14-1* strains shifted to 37°C, in which half of the preparation was subjected to an additional λ phosphatase treatment step ([Figure 6](#fig6){ref-type="fig"}C). When increasing amounts of these two proteins were incubated with 5′-flap and HJ DNA ([Figure 6](#fig6){ref-type="fig"}D), we observed that the dephosphorylated version of Yen1 was approximately 8-fold more active than Yen1^P^. These results demonstrate that phosphorylation has a direct influence on the catalytic activity of Yen1.

To investigate the molecular basis for this difference in activity, we compared the ability of Yen1^λ^ and Yen1^P^ to bind DNA. Using electrophoretic mobility shift assays, carried out with ^32^P-labeled double-stranded, 5′-flap, and HJ DNAs, we observed that Yen1^λ^ exhibited a significantly greater ability to bind DNA than phosphorylated Yen1^P^ ([Figure 6](#fig6){ref-type="fig"}E, compare upper and lower panels). These results indicate that phosphorylation reduces the general affinity of Yen1 for its DNA substrates, which directly affects its catalytic activity.

Discussion {#sec3}
==========

The careful regulation of activities that can process recombination intermediates is essential for proper chromosome segregation and the avoidance of genome instability. The primary mechanism to remove double Holliday junctions involves the STR complex, which promotes dissolution reactions leading to NCO formation. To ensure that this pathway is favored in S phase, the activities of the Holliday junction resolving nucleases, Mus81-Mms4 and Yen1, are held in check by cycles of phosphorylation and dephosphorylation. Recent work defined the mechanism by which Mus81-Mms4 is hyperactivated at G2/M by Cdk/Cdc5-mediated phosphorylation, to provide a first wave of Holliday junction resolution activity that captures and processes persistent junctions that have escaped the attention of STR ([@bib13; @bib18; @bib34; @bib35; @bib38; @bib42]). Until now, however, little was known about the mechanism by which the second wave of HJ resolution, mediated by Yen1, might be regulated. Here, we have shown that Yen1 undergoes a dual mode of regulation, in which both its subcellular localization and nuclease activation are carefully controlled by changes to its phosphorylation status.

First, we found that phosphorylation drives the exclusion of Yen1 from the nucleus in S phase. Consistent with previous observations ([@bib30]), we observed that phosphorylation of S679, a residue that overlaps the nuclear localization sequence, plays an important role in ensuring the cytoplasmic localization of Yen1 by impairing nuclear import. However, phosphoregulation of the NLS alone does not fully account for the localization of Yen1 because a single mutation at this site (Yen1^S679A^) was insufficient to promote nuclear localization to the same extent as Yen1^ON^ (in which nine phosphorylation sites were mutated). In this regard, it is interesting to note that wild-type Yen1 shows strong nuclear enrichment in null mutants lacking the β-karyopherin Msn5 protein ([@bib30]). As reported for other Msn5 cargos, phosphorylation might play an important role in enhancing the nuclear export of Yen1 ([@bib28]). At anaphase, dephosphorylation of Yen1 S679 and other phosphoresidues restores NLS functionality and potentially impairs nuclear export, resulting in the rapid accumulation of Yen1 in the nucleus.

Second, we found that phosphorylation has a direct inhibitory effect on Yen1 nuclease activity. By purifying Yen1 proteins in their phosphorylated and nonphosphorylated states, we directly compared their DNA binding and nuclease activities and found that phosphorylation hinders the ability of Yen1 to process its substrates by a strikingly simple mechanism: inhibition of DNA binding, which directly impacts upon its catalytic activity. Although the precise molecular basis for the reduction of DNA binding imposed by phosphorylation is presently unknown, our observations indicate that Cdk sites located in the central region of Yen1 are important for S phase inactivation ([Figure S1](#app2){ref-type="sec"}). We therefore propose two possible hypotheses: (1) that the central region might undergo a phosphorylation-dependent conformational change that influences DNA binding activity, or (2) that the central region itself is directly required for DNA interaction, or stability of the protein-DNA complex, and that its substrate affinity is reduced by the increased negative charge caused by phosphorylation.

The direct regulation of a nuclease activity by sequential cycles of phosphorylation and dephosphorylation is somewhat unusual. There are, however, suggestions that other members of the XPG-family of structure-selective nucleases, to which Yen1 belongs, are also negatively regulated by phosphorylation events. For instance, phosphorylation of yeast Exo1 and human EXO1 by the DNA damage checkpoint kinases downregulates their ability to promote DNA resection and leads to proteasomal degradation ([@bib15; @bib16; @bib36]). The 5′-flap endonuclease FEN1 is also subject to phosphorylation, which affects its localization, degradation, nuclease activity, and ability to interact with PCNA ([@bib20; @bib21; @bib22]). Phosphorylation, however, does not affect FEN1's affinity for DNA. Yen1 provides an example for the regulation of a structure-selective nuclease by the direct modification of its DNA binding properties through changes to its phosphorylation status.

So how are the two separate layers of control over Yen1 function enforced and coordinated with cell-cycle progression? Yen1 contains nine consensus Cdk sites and is known to be one of many Cdk substrates ([@bib43]). Previous work and our own results indicate that the changes in Yen1 localization are dependent on Cdk-mediated phosphorylation ([@bib30]). Moreover, we found that Cdk-mediated phosphorylation inhibits Yen1 nuclease activity in S phase. Because Yen1 is a specific target of the S phase Cdk complex, Cdc28-Clb5 ([@bib32]), the spatial and temporal inhibition of Yen1 activity might be one of the earliest events to occur as cells enter S phase.

The dual inhibitory actions of Cdk-mediated phosphorylation of Yen1 are reversed by the mitotic exit phosphatase Cdc14, which is sequestered in the nucleolus throughout most of the cell cycle, but is released in two bursts at anaphase ([@bib39; @bib45]). Cdc14 associates with Yen1 and promotes its dephosphorylation, triggering both its nuclear enrichment and increased DNA binding affinity. Therefore, whereas the two levels of control on Yen1 function are to some extent separable, they are interconnected through their common dependence on the master cell-cycle regulators Cdk and Cdc14, which determine the accurate timing of the second wave of joint molecule resolution. A model for the bimodal regulation of Yen1 by Cdk and Cdc14 is shown in [Figure 7](#fig7){ref-type="fig"}A.

But why is it so critical to limit the actions of Yen1 to anaphase? The answer to this question was provided by our analysis of cells carrying constitutively active Yen1^ON^ ([Figure 7](#fig7){ref-type="fig"}B). The nuclear exclusion and inhibition of Yen1 activity in S/G2 has two purposes. First, it restricts its HJ resolvase activity in order to facilitate dHJ processing by the STR complex, thus favoring NCO formation. In this regard, our results demonstrated that a deregulated form of Yen1 could compete for HR intermediates that are normally channeled toward NCOs and instead redirect them to COs, with a concomitant increase in LOH, despite the presence of the STR pathway. Interestingly, similar increases in CO frequency and LOH were observed following the deregulation of Mus81-Mms4 ([@bib35; @bib42]). Second, it ensures that the 5′ flap/fork endonuclease activity of Yen1 will not have access to DNA structures such as replication forks and/or early recombination intermediates that may arise in S/G2, because they may be susceptible to nucleolytic cleavage. In contrast to the deregulation of Mus81-Mms4, however, we found that constitutive activation of Yen1 led to a hypersensitivity to genotoxic stress. One possibility for this difference is the structure selectivity of Yen1 compared with Mus81-Mms4. For example, exposed replication forks might be cleaved on the leading strand by Mus81-Mms4, whereas Yen1 could promote lagging strand cleavage, with potentially different outcomes for repair.

Taken together, our results indicate that cells reserve the efficient, but potentially dangerous, activity of Yen1 until anaphase, when it is unleashed as a last resort to remove persistent HR intermediates that could interfere with chromosome segregation. Cdk and Cdc14 enforce this deliberate delay of the second wave of JM resolution in order to prevent the inappropriate actions of Yen1 in S phase, which could lead to genome instability.

Experimental Procedures {#sec4}
=======================

All experimental procedures are described in detail in [Supplemental Information](#app2){ref-type="sec"}.

Yeast Strains and Cultures {#sec4.1}
--------------------------

All strains employed are described in [Table S2](#app2){ref-type="sec"}. Synchronous release of mitotic cultures and DNA damage sensitivity assays were carried out as described ([@bib3]). S phase arrests were performed by addition of HU to 150 mM, followed by 2--2.5 hr incubation.

Protein Analysis and Nuclease Assays on Beads {#sec4.2}
---------------------------------------------

TCA lysates, soluble lysates, and affinity-purified proteins were analyzed by SDS-PAGE followed by western blotting. Myc-tagged Yen1 was detected using an α-myc antibody. For nuclease assays on beads, Yen1-myc9 was immunoaffinity purified, and the beads were washed extensively and supplemented with 10 μl of resolution buffer (50 mM Tris-HCl \[pH 7.5\], 1 mM MgCl~2~) containing ∼0.5 nM 5′-^32^P-end-labeled synthetic Holliday junction ([@bib26]). Reactions were typically incubated for 15--20 min at 30°C and stopped by SDS/proteinase K deproteinization. Radiolabeled products were separated by PAGE and analyzed by autoradiography or phosphorimaging.

Genetic Analysis of Recombination {#sec4.3}
---------------------------------

Analysis of recombination outcome during mitotic DSB repair was performed as described ([@bib23]).

Protein Purification and Biochemical Assays {#sec4.4}
-------------------------------------------

Yen1-FTH (Yen1-3xFLAG-2xTEV-10xHis) proteins were purified from yeast lysates by two consecutive rounds of affinity chromatography. For the generation of dephosphorylated Yen1-FTH, protein preps were treated with λ phosphatase as part of the purification scheme. Nuclease assays were carried out using purified Yen1 proteins and 10 nM unlabeled DNA (supplemented with ∼0.2 nM 5′-^32^P-end-labeled DNA) in 50 mM Tris-HCl (pH 7.5), 1 mM MgCl~2~, 50 mM NaCl, and 2% glycerol. DNA binding assays were carried out on ice by mixing Yen1 with DNA in binding buffer (50 mM Tris-HCl \[pH 7.5\], 125 mM NaCl, 5 mM EDTA, 1 mM DTT, 100 μg/ml BSA, 11% glycerol, and 2 ng/μl duplex poly dIdC). Protein-DNA complexes were separated by 5% PAGE, and radiolabeled DNAs were visualized. Radiolabeled products were analyzed by autoradiography.
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![Yen1^ON^ Is a Constitutively Active Version of Yen1\
(A) Schematic representation of Yen1, indicating the 25 phosphoresidues identified by mass spectrometry (above) and the nine predicted Cdk consensus target sites (below). Cdk sites are highlighted in red.\
(B) Analysis of the nuclease activity of Yen1^ON^. Soluble lysates were prepared from asynchronous cultures of strains in which *YEN1-myc9*, nuclease-dead *YEN1*^*EEAA*^*-myc9*, and *YEN1*^*ON*^*-myc9* alleles replaced endogenous *YEN1*. Following α-myc immunoaffinity purification, the IPs were analyzed by western blotting and for nuclease activity using ^32^P-labeled Holliday junction DNA. Upper panel: western blots of the lysate and IP, with Pgk1 as a loading control. Lower panel: resolution assays. (−), untreated substrate.\
(C) Yen1^ON^ overexpression causes increased MMS sensitivity. Ten-fold dilutions of wild-type strain BY4741 transformed with centromeric plasmids carrying different *YEN1* alleles (see [Figure S1](#app2){ref-type="sec"}) were plated on SC-URA with or without MMS and imaged after 3 days.\
(D) Yen1^ON^ activity escapes cell-cycle control. The activity profiles of Yen1-myc9, Yen1^EEAA^-myc9 and Yen1^ON^-myc9 were analyzed as in (B) following their immunoprecipitation from synchronized cultures. As, asynchronous culture; G1, α-factor treated culture; S, S and G2 cells 25 min after α-factor release; M, G2/M cells 60 min after α-factor release.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![Premature Activation of Yen1 Causes Increased DNA Damage Sensitivity and Loss of Heterozygosity\
(A) Expression of Yen1^ON^ at physiological levels causes MMS sensitivity. Assays were carried out as described in [Figure 1](#fig1){ref-type="fig"}C, using strains in which endogenous *YEN1* was replaced by the indicated *YEN1* alleles. Cells were plated on YPD containing the indicated amount of drugs.\
(B) *YEN1*^*ON*^ suppresses the DNA damage sensitivity of *mus81Δ* mutants. As in (A), but employing strains deleted for *MUS81*.\
(C) Mild suppression of the MMS sensitivity of *sgs1Δ* mutants by *YEN1*^*ON*^.\
(D) *YEN1*^*ON*^ suppresses the synthetic lethality of *mus81Δ sgs1Δ* double mutants. Diploid strains homozygous for the indicated *YEN1* alleles and heterozygous for *MUS81*/*mus81Δ* and *sgs1Δ*/*SGS1* were sporulated and analyzed by tetrad dissection. Images were taken after 3 days incubation at 30°C. The expected position of each *mus81Δ sgs1Δ* colony is indicated (red circles).\
(E) *YEN1*^*ON*^ promotes crossover formation and loss of heterozygosity during mitotic recombination. The percentage of different recombination events in *YEN1* and *YEN1*^*ON*^ strains is indicated. CO, crossovers; NCO, noncrossovers; BIR, break-induced replication. LOH indicates the total loss of heterozygosity (the sum of CO and BIR events). p values were calculated using a chi-square test with Pearson's correction.\
See also [Table S1](#app2){ref-type="sec"}.](gr2){#fig2}

![Biochemical Activation and Subcellular Localization Are Independent Layers of Yen1 Regulation\
(A) Nuclear localization of Yen1 throughout the cell cycle. Yen1-myc18 at different stages of the cell cycle was analyzed by immunofluorescence. Spindle morphology and DNA were visualized using anti-tubulin antibodies and DAPI. The contours of the cells, determined from differential interference contrast (DIC) images, are depicted by a dotted line.\
(B) As in (A), but with Yen1^ON^.\
(C) Subcellular localization of Yen1 phosphomutants. Nuclear enrichment (as opposed to diffuse pan-cellular staining) of the indicated Yen1 mutants was analyzed as in (A) and quantified (200 cells per condition). The schematic indicates the mutations at the Cdk sites in each allele. Protein domains are colored as in [Figure 1](#fig1){ref-type="fig"}A.\
(D) Analysis of the biochemical activities of the Yen1 mutants used in (C). Myc9-tagged proteins were immunoprecipitated from S phase-arrested cells, and their nuclease activities were assayed.\
(E) Suppression of the *mus81Δ* phenotype depends on both the biochemical activation and nuclear localization of Yen1. *mus81Δ* strains carrying the indicated *YEN1* alleles were analyzed as in [Figure 2](#fig2){ref-type="fig"}B.](gr3){#fig3}

![Cdk and Cdc14 Phosphatase Regulate the Nuclease Activity and Subcellular Localization of Yen1\
(A) Schematic representation of the experimental conditions employed in the Cdk inhibition experiments (B and C).\
(B) Cdk inhibition in S phase cells increases Yen1 activity. *cdc28-as1* cells carrying galactose-inducible *YEN1-myc9* were treated with HU. To one-half of the culture, galactose was added before DMSO (lane 1) or the Cdc28-as1 kinase inhibitor 1NM-PP1 (lane 2). The other half was split, and galactose was added after DMSO (lane 3) or 1NM-PP1 (lane 4). Yen1-myc9 was immunoprecipitated and assayed for HJ resolution.\
(C) Yen1^ON^ activity is refractory to Cdk inhibition. As in (B), except that *YEN1*^*ON*^*-myc9* was expressed after addition of DMSO (3) or 1NM-PP1 (4). The amounts of immunoprecipitated protein were reduced compared with (B) in order to limit DNA cleavage.\
(D) *cdc14-1* mutants fail to activate Yen1 at restrictive temperature. Yen1-myc9 IPs from the indicated strains (grown at 25°C and then shifted to 37°C for 2 hr) were tested for nuclease activity.\
(E) Yen1^ON^ activity is refractory to Cdc14 inactivation. As in (D), but employing *cdc14-1* strains carrying either *YEN1-myc9* or *YEN1*^*ON*^*-myc9*.\
(F) Cdc14 is required for nuclear enrichment of Yen1 at anaphase. The immunofluorescence analysis of Yen1-myc18 or Yen1^ON^-myc18 during anaphase in *CDC14* or *cdc14-1* strains at the restrictive temperature was carried out as in [Figure 3](#fig3){ref-type="fig"}. The percentage of the cells displaying the most representative type of Yen1 distribution (nuclear or cellular) is shown. The contours of the cells, determined from DIC images, are depicted by a dotted line.](gr4){#fig4}

![Direct Activation of Yen1 by Cdc14 Phosphatase\
(A) Analysis of Yen1 activity in *TAB6-1* (*CDC14*^*P116L*^) mutants. Yen1-myc9 IPs from *CDC14* and *TAB6-1* strains treated with HU (enriched at the G1/S phase transition) were tested for nuclease activity.\
(B) Overexpression of Cdc14 in cycling cells results in Yen1 activation. Cycling cultures of the indicated strains were supplemented with 2% galactose for 2 hr to induce Cdc14 expression. As controls, similar cultures were left uninduced. Lysates and IPs were analyzed as described in [Figure 1](#fig1){ref-type="fig"}A.\
(C) Dephosphorylation and activation of Yen1 by ectopic overexpression of Cdc14 in HU-treated cells. The indicated strains were blocked at G1/S and Cdc14 expression was induced by adding 2% galactose for 2 hr. As, asynchronous culture.\
(D) Physical interactions between Yen1 and Cdc14. P~*GAL1*~*-CDC14* mutants were induced by addition of 0.5% galactose for 90 min. For each culture, lysates were prepared and split into two, and proteins were immunoprecipitated with either α-FLAG or α-myc. Proteins were analyzed by western blotting.](gr5){#fig5}

![Phosphorylation of Yen1 Modulates DNA Binding\
(A) FTH-tagged Yen1, Yen1^EEAA^, and Yen1^ON^ were purified from asynchronous cells and analyzed by SDS-PAGE and Coomassie staining (1 μg each).\
(B) Yen1^ON^ exhibits elevated nuclease activity. FTH-tagged Yen1 (Y), Yen1^EEAA^ (E), and Yen1^ON^ (O) (10 nM) were analyzed for nuclease activity using a static Holliday junction X0, nicked HJ X0, mobile HJ X26, replication fork, 5′-flap (upper panel); 3′-flap, splayed arm, double-stranded DNA (dsDNA) (60 bp), oligo dT~60~, and dsDNA (120 bp). (−): no protein.\
(C) SDS-PAGE of purified Yen1^P^ and Yen1^λ^ (1 μg each). Yen1-FTH was expressed in *cdc14-1* cells arrested at 37°C and purified without (Yen1^P^) or with (Yen1^λ^) λ-phosphatase treatment.\
(D) Phosphorylated Yen1 exhibits reduced nuclease activity. Upper panels: increasing amounts of Yen1^λ^ or Yen1^P^ (0, 0.25, 0.5, 1, 2, 4, 8, 16 nM) were incubated with 5′-flap DNA. Lower panels: Yen1^λ^ or Yen1^P^ (0, 1, 2, 4, 8, 16, 32, 64 nM) with HJ X0.\
(E) Yen1^P^ exhibits reduced ability to bind DNA. DNA binding assays were carried out using dsDNA, 5′-flap, and X0 HJ DNA, with either Yen1^λ^ (upper panel) or Yen1^P^ (lower panel). Proteins were used at 0, 10, 20, 40, 80, 160, and 320 nM.](gr6){#fig6}

![Regulatory Control of Yen1 by Cdk and Cdc14\
(A) Cdk and Cdc14 control the phosphorylation status of Yen1. In S phase, Cdk phosphorylates Yen1 to (1) promote its nuclear exclusion by impairing its NLS function and, potentially, enhance Msn5-dependent export, and (2) reduce its DNA binding affinity, avoiding the cleavage of S phase-specific DNA structures such as replication or early recombination intermediates. At anaphase, Cdc14 dephosphorylates Yen1 to reinstate a fully functional NLS and potentially block Msn5-mediated export, leading to its nuclear accumulation. Additionally, the removal of phosphate groups increases the DNA binding affinity and catalytic activity of Yen1, allowing it to resolve HR intermediates that have persisted until anaphase. Red circles (P) depict phosphate groups.\
(B) Yen1^ON^ cannot be turned off or shuttled to the cytoplasm by Cdk. This may lead to the unscheduled and detrimental cleavage of replication or early recombination intermediates. In mutants that accumulate HR intermediates, the constitutive activation of Yen1^ON^ provides an alternative way to process these potentially toxic DNA structures.](gr7){#fig7}
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